Keywords
Breast implants
Submitted : 2021-12-21
Accepted : 2022-01-05
Published : 2022-01-20
Abstract
Primary lymphoma involving the breast accounts for only 0.04–0.5% of malignant breast tumors, constituting 1–2 % of all non-Hodgkin lymphomas (NHL). Here, we report a case of breast ALK-positive ALCL arising in a 21-year-old woman in pregnancy with single abscess as the first clinical manifestation.
References
Talwalkar SS, Miranda RN, Valbuena JR, et al., 2008, Lymphomas Involving the Breast: A Study of 106 Cases Comparing Localized and Disseminated Neoplasms [J]. Am J Surg Pathology, 32(9): 1299–1309.
Lv X, Yu C, Zhao S, et al., 2015, The Progress of Primary Breast Lymphoma. Modern Oncology, 8(23): 1149–1151.
Roden AC, Macon WR, Keeney GL, et al., 2008, Seroma-Associated Primary Anaplastic Large Cell Lymphoma Adjacent to Breast Implants: An Indolent T Cell Lymphoproliferative Disorder. Mod Pathol, 21(4): 455–463.
Lazzeri D, Agostini T, Bocci G, et al., 2011, ALK-Negative Anaplastic Large Cell Lymphoma Associated with Breast Implants: A New Clinical Entity. Clin Breast Cancer, 11: 283–296.
Carty MJ, Pribaz JJ, Antin JH, et al., 2011, A Patient Death Attributable to Implant-Related Primary Anaplastic Large Cell Lymphoma of the Breast. Plast Reconstr Surg, 128: 112e–118e.
Gui L, Shi Y, He X, et al., 2015, Clinicopathological Features and Outcomes: Analysis of 21 Cases of Lymphoma in Pregnancy. Zhonghua Yi Xue Za Zhi, 95(6): 425–429.
Xu J, Wei S, 2014, Breast Implant-Associated Anaplastic Large Cell Lymphoma: Review of a Distinct Clinicopathologic Entity. Arch Pathol Lab Med, 138(6): 842–846.
Ramos-Gallardo G, Cuenca-Pardo J, 2016, Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis. J Invest Surg, 18: 1–10.
Kadin ME, Deva A, 2016, Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J, 36(7): 773–781.
Lechner MG, Lade S, Liebertz DJ, et al., 2011, Breast Implant-Associated, ALK-Negative, T-cell, Anaplastic, Large-Cell Lymphoma: Establishment and Characterization of a Model Cell Line (TLBR-1) for This Newly Emerging Clinical Entity. Cancer, 117: 1478–1489.
Story SK, Schowalter MK, Geskin LJ, 2013, Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders. Oncologist, 18: 301–307.
George EV, Pharm J, Houston C, et al., 2013, Breast Implant-Associated ALK-Negative Anaplastic Large Cell Lymphoma:A Case Report and Discussion of Possible Pathogenesis. Int J Clin Exp Pathol, 6(8): 1631–1642.
Kim B, Zachary S, Predmore BA, et al., 2015, Breast Implant-Associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process. Plast Reconstr Surg Glob Open, 3(1): e296.
Miranda RN, Aladily TN, Prince HM, et al. 2014, Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients. J Clin Oncol, 32: 114–120.
Pereg D, Koren G, Lishner M, 2007, The Treatment of Hodgkin’s and non-Hodgkin’s Lymphoma in Pregnancy. Haematologica, 92: 1230–1237.